Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 3681 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Active Pharmaceutical Ingredient CDMO Market Analysis Report 2024-2030: Patient Expiration, Expanding Consumption of Biopharmaceuticals, Demand for Generic Drugs Driving Expansion

Read more ››

By: PR Newswire Association LLC. - 27 Mar 2024

Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Surgery Partners, Inc

argenx Announces Annual General Meeting of Shareholders on May 7, 2024

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: argenx SE

INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: INmune Bio Inc.

Aptose Reports Results for the Fourth Quarter and Full Year 2023

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Aptose Biosciences Inc.

BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: BioAtla©, Inc.

Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Galapagos NV

Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Korro Bio, Inc.

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Voyager Therapeutics, Inc.

ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: ProSomnus Inc.

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: IRIDEX Corporation

Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Kane Biotech Inc.

Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Humacyte, Inc.

Stryker announces Annual Meeting of Shareholders

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Stryker Corporation

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Biora Therapeutics, Inc.

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Sight Sciences, Inc.

Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Annexon, Inc. | Annexin Pharmaceuticals AB (publ)

OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: OrthoPediatrics Corp.

Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Panbela Therapeutics, Inc.

Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Zevra Therapeutics, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑